Increased body weight associated with prolactin secreting pituitary adenomas: weight loss with normalization of prolactin levels. Clin Endocrinol (Oxf), 48 () . La presencia de macroprolactina sérica es un hecho relativamente frecuente que puede conducir a exploraciones costosas y tratamientos ineficaces. Manejo terapéutico de la hiperprolactinemia. Therapeutic management of hyperprolactinemia. Visits. J M. Cabezas Agrícolaa, J. Cabezas-Cerratoa.

Author: Mezinris Kajisida
Country: Mali
Language: English (Spanish)
Genre: Spiritual
Published (Last): 28 July 2007
Pages: 458
PDF File Size: 9.39 Mb
ePub File Size: 20.11 Mb
ISBN: 404-9-47758-176-1
Downloads: 6654
Price: Free* [*Free Regsitration Required]
Uploader: Kishura

J Clin Endocrinol Metab, 87pp. Endokrynol Pol, 34pp.

Continuing navigation will be considered as acceptance of this use. Among its adverse effects considered as “very hperprolactinemia is included the ability to induce fibrotic changes in cardiac valvular hhiperprolactinemia first described in patients with Parkinson disease using doses higher than those usually used in hyperprolactinemia treatment.

Recurrence of hyperprolactinemia after selective transphenoidal adenomectomy in women with prolactinoma. It is important to erform bone densitometry in these patients and to identify the cases of osteoporosis and to start opportune treatment.

[Current diagnosis and treatment of hyperprolactinemia].

The Impact Articilo measures the average number of citations received in a particular year by papers published in the journal during the two receding years. Sem Arthritis Rheum, 34pp. Prolactinomas are usually classified as microprolactinomas less than 1 cm or macroprolactinomas larger than 1 cmwhich can either be confined or invasive.


Joint Bone Spine, 71pp.

July Pages Prevalence of subclinic thyroid disease in mexican systemic sclerosis patients. Prolactin synthesis by lymphocytes from patients with systemic sclerosis. J Clin Endocrinol Metab, 62pp. This item has received. Withdrawal of long-term cabergoline therapy for tumoral and articklo hyperprolactinemia.

Are you a health professional able to prescribe or dispense drugs?

Clin Endocrinol Oxf56pp. Artkculo Paul Med,pp. Previous article Next article. After observing the evolution of these patients, spontaneously or under treatment with dopaminergic agonists, a clear relationship of causality between the presence of macroprolactin and the clinical manifestations was not found, except in a case of galactorrhea.

Dehydroepiandrosterone sulphate serum levels in systemic sclerosis.

Changes in computed tomographic findings in microprolactinomas before and after bromocriptine. Circulating lipids articklo minor abnormalities of thyroid function. Am Heart J,pp. Print Send to a friend Export reference Mendeley Statistics. Osteopenia in systemic sclerosis: It is important to erform bone densitometry in these patients and to identify the cases of osteoporosis and to start opportune treatment.


[Current diagnosis and treatment of hyperprolactinemia].

The osteoporosis in escleroderma is multifactorial ischemia, immobilization, intestinal malabsorption syndrome, steroids, menopause, hyperprolactinemia, among other. N Engl J Med,pp. All the studies on hyperprolactinemia should not forged the possible presence of macroprolactinemia. J Rheumatol, 22pp.

N Engl J Med,pp. Endocr Rev, 13pp. SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field. Endocrinol Metab Clin North Am, 28pp. Hyperprolactinemia due to macroprolactin and erectile dysfunction. Ann Dermatol Venereol,pp. Clin Rheum, 10pp. Cabergoline and bromocriptine are dopaminergic agonists drugs used in hyperprolactinemia treatment, as well as in patients with Parkinson’s disease.

Low doses of dopamine agonists in the longterm treatment of macroprolactinomas. J Endocrinol Invest, 26pp. Clin Exp Rheumatol, 23pp. J Rheumatol, 13pp.